K Miller, R Morant, A Stenzl, I Zuna, M Wirth - Urol Int, 2016 - core.ac.uk
Introduction: This phase II trial evaluated the efficacy and safety of the epidermal growth
factor receptor (EGFR) tyrosine kinase inhibitor, gefitinib, in combination with first-line …